Role of Lipid Profile and Its Relative Ratios (Cholesterol/HDL-C, Triglyceride/HDL-C, LDL-C/HDL-C, WBC/HDL-C, and FBG/HDL-C) on Admission Predicts In-Hospital Mortality COVID-19

被引:14
|
作者
Mohammadshahi, Jafar [1 ]
Ghobadi, Hassan [2 ]
Matinfar, Golchin [3 ]
Boskabady, Mohammad Hossein [4 ]
Aslani, Mohammad Reza [2 ,4 ]
机构
[1] Ardabil Univ Med Sci, Sch Med, Dept Infect Dis & Trop Med, Ardebil, Iran
[2] Ardabil Univ Med Sci, Lung Dis Res Ctr, Ardebil, Iran
[3] Ardabil Univ Med Sci, Fac Med, Ardebil, Iran
[4] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
关键词
HIGH-DENSITY-LIPOPROTEIN; TRACHEAL RESPONSIVENESS; DIABETES-MELLITUS; METHACHOLINE; DIET;
D O I
10.1155/2023/6329873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background. Lipid profile and its related ratios such as total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), TG/HDL-C ratio, TC/HDL-C ratio, LDL-C/HDL-C ratio, white blood cell (WBC)/HDL-C ratio, and fasting blood glucose (FBG)/HDL-C ratio are valuable indicators that have been studied in various disorders to predict mortality. The present study was conducted with the aim of investigating the role of lipid profile ratios in predicting mortality in COVID-19 patients. Methods. At the beginning of hospitalization, laboratory tests were taken from all patients (n=300). The ability of lipid profile ratios to determine the COVID-19 severity was evaluated using receiver-operating characteristic (ROC). In addition, survival probability was determined with the average of Kaplan-Meier curves, so that the end point was death. Results. In deceased patients, TG, TC, LDL-C, HDL-C, TC/HDL-C, TG/HDL-C, and LDL-C/HDL-C parameters were significantly lower than those of surviving patients, while WBC/HDL-C and FBG/HDL-C were significantly higher. TC (HR=3.178, 95%CI=1.064 to 9.491, P<0.05), TG (HR=3.276, 95%CI=1.111 to 9.655, P<0.05), LDL-C (HR=3.207, 95%CI=1.104 to 9.316, P<0.05), and HDL-C (HR=3.690, 95%CI=1.290 to 10.554, P<0.05), as well as TC/HDL-C (HR=3.860, 95%CI=1.289 to 11.558, P<0.05), TG/HDL-C (HR=3.860, 95%CI=1.289 to 11.558, P<0.05), LDL-C/HDL-C (HR=3.915, 95%CI=1.305 to 11.739, P<0.05), WBC/HDL-C (HR=3.232, 95%CI=1.176 to 8.885, P<0.05), and FBG/HDL-C ratios (HR=4.474, 95%CI=1.567 to 12.777, P<0.01), were detectably related to survival. The multivariate Cox regression models showed that only FBG/HDL-C ratio (HR=5.477, 95%CI=1.488 to 20.153, P<0.01) was significantly related to survival. Conclusion. The results suggested that FBG/HDL-C ratio in hospital-admitted COVID-19 patients was a reliable predictor of mortality.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients
    Xia, Wenkai
    Yao, Xiajuan
    Chen, Yan
    Lin, Jie
    Vielhauer, Volker
    Hu, Hong
    BMC NEPHROLOGY, 2020, 21 (01)
  • [2] Association of the TG/HDL-C and Non-HDL-C/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population
    Wen, Jia
    Chen, Yiyin
    Huang, Yun
    Lu, Yao
    Liu, Xing
    Zhou, Honghao
    Yuan, Hong
    KIDNEY & BLOOD PRESSURE RESEARCH, 2017, 42 (06) : 1141 - 1154
  • [3] HDL-C: Role as a risk modifier
    Barter, Philip
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (03) : 267 - 270
  • [4] Waist-to-height ratio (WHtR) and triglyceride to HDL-c ratio (TG/HDL-c) as predictors of cardiometabolic risk
    Weiler Miralles, Clara Silvana
    Wollinger, Luana Maria
    Mann, Debora
    Genro, Julia Pasqualini
    Contini, Veronica
    Dal Bosco, Simone Morelo
    NUTRICION HOSPITALARIA, 2015, 31 (05) : 2115 - 2121
  • [5] Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C
    Miller, M
    Dobs, A
    Yuan, Z
    Battisti, WP
    Borisute, H
    Palmisano, J
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) : 1087 - 1094
  • [6] HDL-C concentration is related to markers of absorption and of cholesterol synthesis: Study in subjects with low vs. high HDL-C
    Nunes, V. S.
    Leanca, C. C.
    Panzoldo, N. B.
    Parra, E.
    Cazita, P. M.
    Nakandakare, E. R.
    de Faria, E. C.
    Quintao, E. C. R.
    CLINICA CHIMICA ACTA, 2011, 412 (1-2) : 176 - 180
  • [7] New Drugs for HDL-C Disorders: The Beginning
    MyNgan Duong
    Nicholls, Stephen J.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (25) : 2947 - 2951
  • [8] Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c
    Hajer, G. R.
    van der Graaf, Y.
    Bots, M. L.
    Algra, A.
    Visseren, F. L. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 680 - 688
  • [9] The beneficial effects of HDL-C on atherosclerosis: rationale and clinical results
    Santos-Gallego, Carlos G.
    Torres, Francisco
    Jose Badimon, Juan
    CLINICAL LIPIDOLOGY, 2011, 6 (02) : 181 - 208
  • [10] Investigational drugs targeting HDL-C metabolism and reverse cholesterol transport
    Robinson, Jennifer G.
    Davidson, Michael H.
    FUTURE LIPIDOLOGY, 2007, 2 (03): : 285 - 301